New Zealand markets closed

NRx Pharmaceuticals, Inc. (NRXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.4381+0.0791 (+22.03%)
At close: 04:00PM EST
0.4398 +0.00 (+0.39%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close0.3590
Bid0.0000 x 800
Ask0.0000 x 1400
Day's range0.3700 - 0.4440
52-week range0.2210 - 1.2000
Avg. volume1,259,833
Market cap40.163M
Beta (5Y monthly)1.00
PE ratio (TTM)N/A
EPS (TTM)-0.5000
Earnings date28 Mar 2024 - 01 Apr 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est3.17
  • Simply Wall St.

    Positive Signs As Multiple Insiders Buy NRx Pharmaceuticals Stock

    Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...

  • PR Newswire

    NRx Pharmaceuticals Announces Definitive Purchase Agreement for Common, Unregistered Shares at $0.38 per Share

    NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it entered into a definitive purchase agreement subject to standard closing conditions with an accredited investor to purchase approximately 2.7 million shares of unregistered common stock at $0.38 per share, along with an equal number warrants to purchase common stock at $0.40 per share; the term on these warrants is five (5) years. The price of $0.38

  • PR Newswire

    /C O R R E C T I O N -- NRx Pharmaceuticals, Inc./

    NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), ("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmaceutical company, today announced the pricing of its underwritten public offering of shares of its common stock (or pre-funded warrants in lieu thereof) at a public offering price of $0.30 per share, for aggregate gross proceeds of approximately $1,500,000, prior to deducting underwriting discounts and other offering expenses. In addition, the Company has granted the underwriters a 45-da